%0 Journal Article
%T Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
%A Vonk MC
%A Assassi S
%A Hoffmann-Vold AM
%J Rheum Dis Clin North Am
%V 49
%N 2
%D 05 2023
%M 37028833
%F 2.032
%R 10.1016/j.rdc.2023.01.003
%X As skin involvement is the hall mark of systemic sclerosis (SSc) and changes of skin involvement have shown to correlate with internal organ involvement, assessing the extend of skin involvement is key. Although the modified Rodnan skin score is a validated tool used to evaluate the skin in SSc, it has its drawbacks. Novel imagine methods are promising but should be further evaluated. As for molecule markers for skin progression there are conflicting data on the predictive significance of baseline SSc skin gene expression profiles, but immune cell type signature in SSc skin correlates with progression.